ISLAMABAD: The Supreme Court on Friday deemed invalid the directives of Ministry of Narcotics Control (MNC) secretary Zafar Abbas Luk to stop the prosecutors’ funds, saying that stoppage of funds was done to create obstacles in the investigation, Express News reported.
Chief Justice Iftikhar Muhammad Chaudhry criticised Luk saying that he was the reason why the investigation was not transparent and also held him responsible for problems associated with it, adding that he was not going to let people get slandered just because their names were in the list.
Earlier during the hearing, secretary narcotics issued offending statements, accusing the Anti-Narcotics Force (ANF) of fabricating cases after he was accused by the ANF lawyer of hampering the investigation and trying to save the accused at all costs.
In retort, Luk accused ANF of fabricating cases and implicating innocent people adding that he had proof of the matter and if the accusations he was making were untrue, he would resign.
Luk went one step further, saying, “Tomorrow ANF might even incriminate the prime minister by planting heroin in his car.”
The chief justice held Luk responsible for problems pertaining to the investigation.
Despite directives from his father, Ali Musa Gilani, son of Prime Minister Yousaf Raza Gilani failed to return to Pakistan to take part in the hearing.
Earlier, Gilani in a statement had asked his son to come back to the country immediately and be party to the investigations of the Ephedrine case.
According to Express News, the Supreme Court has directed Sheikh Rasheed, who pleaded to be party to the case, to contact ANF in this regard.
Rasheed, while talking to the media said that the legal quota for these companies is only 330g each of the banned chemicals used, whereas, he claims they have been allotted 12kg quota each.
He also claimed that these companies, in addition to ephedrine, have been given quota for other banned chemicals including Prazolam, Buprine, Tramadol and Pantazol.
The case regarding the illegal sale of ephedrine was registered on October 10 last year, after two pharmaceutical companies were accused of obtaining export quotas for the drug in collusion with the health ministry officials that exceeded the limits fixed by the INCB.
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ